Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
332
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Celltrion Inc
•
22 Oct 2018 19:04
Celltrion Inc Placement - Shorter Lockup Period Will Be an Overhang for Share Price
Ion Investment (Temasek) is looking to sell about 3.4m shares in Celltrion Inc (068270 KS) in an accelerated bookbuild worth approximately US$740m....
Zhen Zhou, Toh
502 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 Oct 2018 11:49
Smartkarma’s Week that Was in JP/KR: King Street Vs. Toshiba, Korea's Donki, and SKT Split
Below is the list of the Japan/Korea related posts put on the Smartkarma platform last week. It was a holiday week for both Japan and Korea. So, we...
Sanghyun Park
Follow
362 Views
Share
bullish
•
Samsung C&T
•
04 Oct 2018 12:11
Stub Trade on Samsung C&T with BioLogics as a Sole Pair Partner
The last Samsung C&T (028260 KS) block deals ended last month on Sep 20. C&T is now free of circular shareholding links. That is, C&T...
Sanghyun Park
Follow
466 Views
Share
bearish
•
Celltrion Inc
•
21 Sep 2018 20:00
Celltrion: Understanding Inflectra's U.S. Challenges
Celltrion Inc (068270 KS) 's Inflectra (biosimilar of Remicade marketed in the U.S.) has struggled to gain a foothold in the market since its...
Kemp Dolliver, CFA
614 Views
Share
bullish
•
Samsung C&T
•
20 Sep 2018 22:14
Samsung C&T Placement: Finally First Step Towards a Legit Holding Company
I would take this deal. I believe the market will interpret this placement as the starting point of C&T-centered holding company conversion....
Sanghyun Park
Follow
486 Views
Share
First
Previous
46
47
48
49
50
51
52
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.41.4
x